Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023 » 07:56
01/03/23
01/03
07:56
01/03/23
07:56
KNX

Knight-Swift

$52.40 /

-0.125 (-0.24%)

, CASY

Casey's General Stores

$224.28 /

-2.99 (-1.32%)

, WBS

Webster Financial

$47.33 /

+0.21 (+0.45%)

, BKI

Black Knight

$61.71 /

+0.7 (+1.15%)

, CSTL

Castle Biosciences

$23.54 /

+0.25 (+1.07%)

, CRWD

Crowdstrike

$105.28 /

+0.7 (+0.67%)

, MODV

ModivCare

$89.44 /

+0.54 (+0.61%)

, VMC

Vulcan Materials

$175.09 /

-0.92 (-0.52%)

, ASO

Academy Sports

$52.53 /

+0.115 (+0.22%)

, CDMO

Avid Bioservices

$13.77 /

-0.16 (-1.15%)

, WEN

Wendy's

$22.62 /

-0.15 (-0.66%)

, DSGX

Descartes Systems

$69.65 /

-0.57 (-0.81%)

, ONB

Old National Bancorp

$17.99 /

-0.18 (-0.99%)

, WSO

Watsco

$249.44 /

-3.02 (-1.20%)

, FLYW

Flywire

$24.48 /

+0.72 (+3.03%)

, STEL

Stellar Bancorp

$29.52 /

-0.29 (-0.97%)

, GKOS

Glaukos

$43.69 /

+1.13 (+2.66%)

, FFWM

First Foundation

$14.32 /

-0.085 (-0.59%)

, VZIO

Vizio

$7.42 /

+0.02 (+0.27%)

Stephens analysts have…

Stephens analysts have published their 2023 "Best Ideas" list, naming Knight-Swift (KNX), Casey's General Stores (CASY), Webster Financial (WBS), Black Knight (BKI), Castle Biosciences (CSTL), Crowdstrike (CRWD), ModivCare (MODV), Vulcan Materials (VMC), Academy Sports (ASO), Avid Bioservices (CDMO), Wendy's (WEN), Descartes Systems (DSGX), Old National Bancorp (ONB), Watsco (WSO), Flywire (FLYW), Stellar Bancorp (STEL), Glaukos (GKOS), First Foundation (FFWM) and Vizio (VZIO) to the list. As previously reported, the seven stocks that were carried over on the firm's "Best Ideas" list from 2022 included: Casey's General, Crowdstrike, Glaukos, Vizio, Vulcan Materials, Webster Financial and Wendy's.

ShowHide Related Items >><<
WSO Watsco
$249.44 /

-3.02 (-1.20%)

WEN Wendy's
$22.62 /

-0.15 (-0.66%)

WBS Webster Financial
$47.33 /

+0.21 (+0.45%)

VZIO Vizio
$7.42 /

+0.02 (+0.27%)

STEL Stellar Bancorp
$29.52 /

-0.29 (-0.97%)

MODV ModivCare
$89.44 /

+0.54 (+0.61%)

KNX Knight-Swift
$52.40 /

-0.125 (-0.24%)

GKOS Glaukos
$43.69 /

+1.13 (+2.66%)

FLYW Flywire
$24.48 /

+0.72 (+3.03%)

FFWM First Foundation
$14.32 /

-0.085 (-0.59%)

DSGX Descartes Systems
$69.65 /

-0.57 (-0.81%)

CSTL Castle Biosciences
$23.54 /

+0.25 (+1.07%)

CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

CDMO Avid Bioservices
$13.77 /

-0.16 (-1.15%)

CASY Casey's General Stores
$224.28 /

-2.99 (-1.32%)

BKI Black Knight
$61.71 /

+0.7 (+1.15%)

ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

KNX Knight-Swift
$52.40 /

-0.125 (-0.24%)

11/28/22 Deutsche Bank
Knight-Swift price target raised to $69 from $63 at Deutsche Bank
10/20/22 Citi
Knight-Swift price target lowered to $50 from $52 at Citi
10/20/22 KeyBanc
Knight-Swift price target lowered to $60 from $70 at KeyBanc
08/22/22 Evercore ISI
Evercore upgrades Schneider to Outperform on attractive risk/reward
CASY Casey's General Stores
$224.28 /

-2.99 (-1.32%)

12/28/22 Stephens
Stephens carries over seven stocks to 'Best Ideas' list for 2023
12/19/22 Credit Suisse
Casey's General Stores initiated with a Neutral at Credit Suisse
12/08/22 Benchmark
Casey's General Stores price target raised to $275 from $230 at Benchmark
12/08/22 Deutsche Bank
Casey's General Stores price target raised to $291 from $286 at Deutsche Bank
WBS Webster Financial
$47.33 /

+0.21 (+0.45%)

12/13/22 JPMorgan
Webster Financial price target lowered to $50 from $56 at JPMorgan
12/05/22 Morgan Stanley
Webster Financial initiated with an Overweight at Morgan Stanley
11/28/22 Stephens
Webster Financial named a 'Best Idea' at Stephens
BKI Black Knight
$61.71 /

+0.7 (+1.15%)

12/06/22 Raymond James
IntercontinentalExchange price target raised to $130 from $123 at Raymond James
12/02/22 Barclays
Black Knight downgraded to Equal Weight from Overweight at Barclays
11/17/22 BofA
IntercontinentalExchange upgraded to Buy from Neutral at BofA
05/20/22 Jefferies
IntercontinentalExchange price target lowered to $134 from $161 at Jefferies
CSTL Castle Biosciences
$23.54 /

+0.25 (+1.07%)

11/03/22 Baird
Castle Biosciences price target lowered to $41 from $48 at Baird
08/09/22 Baird
Castle Biosciences price target raised to $48 from $44 at Baird
05/19/22 Baird
Baird says final LCD for test 'incrementally positive' for Castle Biosciences
05/10/22 Canaccord
Castle Biosciences price target lowered to $65 from $80 at Canaccord
CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

12/15/22 Wedbush
Wedbush bullish on Crowdstrike, initiates with an Outperform
12/14/22 Wedbush
Crowdstrike initiated with an Outperform at Wedbush
12/09/22 BTIG
Datadog price target lowered to $93 from $104 at BTIG
MODV ModivCare
$89.44 /

+0.54 (+0.61%)

11/04/22 Barrington
ModivCare price target lowered to $138 from $157 at Barrington
08/05/22 Barrington
ModivCare price target raised to $157 from $155 at Barrington
08/02/22 Stephens
ModivCare initiated with an Overweight at Stephens
05/06/22 Deutsche Bank
ModivCare price target lowered to $130 from $150 at Deutsche Bank
VMC Vulcan Materials
$175.09 /

-0.92 (-0.52%)

12/19/22 Stifel
Vulcan Materials price target raised to $227 from $215 at Stifel
12/08/22 JPMorgan
Vulcan Materials upgraded to Overweight from Neutral at JPMorgan
10/12/22 DA Davidson
Vulcan Materials price target lowered to $200 from $205 at DA Davidson
ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

12/14/22 Loop Capital
Academy Sports price target raised to $65 from $60 at Loop Capital
12/08/22 UBS
Academy Sports price target raised to $76 from $60 at UBS
12/08/22 Wedbush
Academy Sports price target raised to $62 from $57 at Wedbush
12/08/22 Loop Capital
Academy Sports price target raised to $65 from $60 at Loop Capital
CDMO Avid Bioservices
$13.77 /

-0.16 (-1.15%)

12/07/22 Craig-Hallum
Avid Bioservices price target lowered to $25 from $30 at Craig-Hallum
06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
WEN Wendy's
$22.62 /

-0.15 (-0.66%)

12/15/22 Jefferies
Wendy's initiated with a Hold at Jefferies
11/10/22 Deutsche Bank
Wendy's price target lowered to $23 from $24 at Deutsche Bank
11/10/22 Citi
Wendy's price target lowered to $22 from $23 at Citi
DSGX Descartes Systems
$69.65 /

-0.57 (-0.81%)

12/08/22 BMO Capital
Descartes Systems price target lowered to $71 from $74 at BMO Capital
12/08/22 Barclays
Descartes Systems price target lowered to $58 from $60 at Barclays
11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Descartes Systems downgraded to Peer Perform from Outperform at Wolfe Research
ONB Old National Bancorp
$17.99 /

-0.18 (-0.99%)

05/13/22 Stephens
Stephens upgrades Old National Bancorp to Overweight after 'waiting patiently'
05/13/22 Stephens
Old National Bancorp upgraded to Overweight from Equal Weight at Stephens
WSO Watsco
$249.44 /

-3.02 (-1.20%)

10/24/22 Deutsche Bank
Watsco price target raised to $294 from $284 at Deutsche Bank
10/20/22 Deutsche Bank
Watsco price target lowered to $284 from $311 at Deutsche Bank
10/12/22 Morgan Stanley
Watsco price target raised to $218 from $217 at Morgan Stanley
09/06/22 KeyBanc
Watsco price target raised to $310 from $300 at KeyBanc
FLYW Flywire
$24.48 /

+0.72 (+3.03%)

10/24/22 Loop Capital
Flywire initiated with a Buy at Loop Capital
09/22/22 Truist
Flywire initiated with a Buy at Truist
07/14/22 Goldman Sachs
Flywire upgraded to Buy from Neutral at Goldman Sachs
06/30/22 Raymond James
Flywire added to 'Analyst Current Favorites' list at Raymond James
STEL Stellar Bancorp
$29.52 /

-0.29 (-0.97%)

12/13/22 Stephens
Stellar Bancorp upgraded to Overweight from Equal Weight at Stephens
10/06/22 Raymond James
Stellar Bancorp assumed with an Outperform at Raymond James
GKOS Glaukos
$43.69 /

+1.13 (+2.66%)

12/28/22 Stephens
Glaukos price target lowered to $68 from $69 at Stephens
12/28/22 Stephens
Cutera price target lowered to $68 from $78 at Stephens
12/22/22 Mizuho
Glaukos initiated with a Neutral at Mizuho
FFWM First Foundation
$14.32 /

-0.085 (-0.59%)

10/26/22 DA Davidson
First Foundation downgraded to Neutral from Buy at DA Davidson
07/27/22 B. Riley
First Foundation price target raised to $23 from $21 at B. Riley
07/11/22 B. Riley
First Foundation downgraded to Neutral from Buy at B. Riley
04/12/22 B. Riley
First Foundation price target lowered to $31 from $34 at B. Riley
VZIO Vizio
$7.42 /

+0.02 (+0.27%)

12/23/22 Needham
Vizio price target lowered to $11 from $16 at Needham
12/01/22 Morgan Stanley
Vizio initiated with an Equal Weight at Morgan Stanley
10/04/22 Stephens
Adeia initiated with an Overweight at Stephens
WSO Watsco
$249.44 /

-3.02 (-1.20%)

WEN Wendy's
$22.62 /

-0.15 (-0.66%)

WBS Webster Financial
$47.33 /

+0.21 (+0.45%)

VZIO Vizio
$7.42 /

+0.02 (+0.27%)

VMC Vulcan Materials
$175.09 /

-0.92 (-0.52%)

STEL Stellar Bancorp
$29.52 /

-0.29 (-0.97%)

ONB Old National Bancorp
$17.99 /

-0.18 (-0.99%)

MODV ModivCare
$89.44 /

+0.54 (+0.61%)

KNX Knight-Swift
$52.40 /

-0.125 (-0.24%)

GKOS Glaukos
$43.69 /

+1.13 (+2.66%)

FLYW Flywire
$24.48 /

+0.72 (+3.03%)

FFWM First Foundation
$14.32 /

-0.085 (-0.59%)

DSGX Descartes Systems
$69.65 /

-0.57 (-0.81%)

CSTL Castle Biosciences
$23.54 /

+0.25 (+1.07%)

CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

CDMO Avid Bioservices
$13.77 /

-0.16 (-1.15%)

CASY Casey's General Stores
$224.28 /

-2.99 (-1.32%)

BKI Black Knight
$61.71 /

+0.7 (+1.15%)

ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

WSO Watsco
$249.44 /

-3.02 (-1.20%)

WEN Wendy's
$22.62 /

-0.15 (-0.66%)

VZIO Vizio
$7.42 /

+0.02 (+0.27%)

CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

WSO Watsco
$249.44 /

-3.02 (-1.20%)

WEN Wendy's
$22.62 /

-0.15 (-0.66%)

VZIO Vizio
$7.42 /

+0.02 (+0.27%)

VMC Vulcan Materials
$175.09 /

-0.92 (-0.52%)

KNX Knight-Swift
$52.40 /

-0.125 (-0.24%)

GKOS Glaukos
$43.69 /

+1.13 (+2.66%)

FLYW Flywire
$24.48 /

+0.72 (+3.03%)

CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

CDMO Avid Bioservices
$13.77 /

-0.16 (-1.15%)

CASY Casey's General Stores
$224.28 /

-2.99 (-1.32%)

BKI Black Knight
$61.71 /

+0.7 (+1.15%)

ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

WEN Wendy's
$22.62 /

-0.15 (-0.66%)

KNX Knight-Swift
$52.40 /

-0.125 (-0.24%)

FFWM First Foundation
$14.32 /

-0.085 (-0.59%)

CRWD Crowdstrike
$105.28 /

+0.7 (+0.67%)

ASO Academy Sports
$52.53 /

+0.115 (+0.22%)

Over a month ago
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:27
12/07/22
12/07
11:27
12/07/22
11:27
NYMX

Nymox

/

+

, ONCT

Oncternal Therapeutics

$1.05 /

-0.025 (-2.33%)

, IOVA

Iovance Biotherapeutics

$7.56 /

-0.04 (-0.53%)

, PLX

Protalix

$1.17 /

-0.01 (-0.85%)

, CDMO

Avid Bioservices

$12.80 /

-2.04 (-13.75%)

These names in the…

ShowHide Related Items >><<
PLX Protalix
$1.17 /

-0.01 (-0.85%)

ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

NYMX Nymox
/

+

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

NYMX Nymox
/

+

ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

08/10/22 H.C. Wainwright
Oncternal Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
05/27/22 Northland
Oncternal updated interim data should be catalyst for shares, says Northland
05/10/22 Maxim
Oncternal Therapeutics initiated with a Buy at Maxim
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
PLX Protalix
$1.17 /

-0.01 (-0.85%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

12/07/22 Craig-Hallum
Avid Bioservices price target lowered to $25 from $30 at Craig-Hallum
06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

NYMX Nymox
/

+

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

Recommendations
Avid Bioservices price target lowered to $25 from $30 at Craig-Hallum » 08:36
12/07/22
12/07
08:36
12/07/22
08:36
CDMO

Avid Bioservices

$14.84 /

-0.565 (-3.67%)

Craig-Hallum analyst Matt…

Craig-Hallum analyst Matt Hewitt lowered the firm's price target on Avid Bioservices to $25 from $30 and keeps a Buy rating on the shares. The analyst notes Avid provided a nice beat on revenues, increased their full year 2023 revenue guidance and commentary on the call was fairly upbeat. Importantly, he believes the company can continue to outperform its peers as it has no COVID exposure, continues to benefit from capacity constraints in the markets it competes in, and has a quality track record that is setting it apart and helping the company win business from new and existing customers.

ShowHide Related Items >><<
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

Earnings
Avid Bioservices raises FY23 revenue view to $145M-$150M from $140M-$145M » 16:18
12/06/22
12/06
16:18
12/06/22
16:18
CDMO

Avid Bioservices

$14.84 /

-0.565 (-3.67%)

Consensus $143.81M. The…

Consensus $143.81M. The company said, "The company is increasing full year revenue guidance for fiscal 2023 from $140 to $145 million to $145 and $150 million... Based on the company's performance during the first six months, we anticipate that fiscal 2023 will be another strong year for Avid. The company's strategic transformation is well underway, and we look forward to achieving the milestones that will position us for consistent growth in the future."

ShowHide Related Items >><<
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

Earnings
Avid Bioservices reports Q2 EPS (2c), consensus 0c » 16:16
12/06/22
12/06
16:16
12/06/22
16:16
CDMO

Avid Bioservices

$14.84 /

-0.565 (-3.67%)

Reports Q2 revenue…

Reports Q2 revenue $34.76M, consensus $32.05M. "The consistent execution by our team has strengthened and expanded our customer base, and significantly improved the company's financial position as compared to prior years. Our topline revenues remain strong and our backlog continues to show strong growth over the prior year. The investment in our business development team is already showing positive results ahead of the completion of our new capacity and services soon to come online. We fully expect this momentum to continue and for all of these reasons, I am pleased to report that Avid is increasing its revenue guidance for the full fiscal year 2023 to between $145 million and $150 million," stated Nick Green, president and chief executive officer of Avid Bioservices.

ShowHide Related Items >><<
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

CDMO Avid Bioservices
$14.84 /

-0.565 (-3.67%)

Hot Stocks
Avid Bioservices appoints Lukash as vice president, people » 08:15
11/16/22
11/16
08:15
11/16/22
08:15
CDMO

Avid Bioservices

$15.55 /

+0.565 (+3.77%)

, OCX

OncoCyte

/

+

Avid Bioservices (CDMO)…

Avid Bioservices (CDMO) announced the appointment of Oksana Lukash, as vice president, people. Lukash has more than 20 years of human resources experience with both established and entrepreneurial organizations across a range of industries. Prior to joining Avid, Lukash served as vice president, people & culture at Oncocyte (OCX), a precision diagnostics company.

ShowHide Related Items >><<
OCX OncoCyte
/

+

CDMO Avid Bioservices
$15.55 /

+0.565 (+3.77%)

CDMO Avid Bioservices
$15.55 /

+0.565 (+3.77%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
OCX OncoCyte
/

+

11/14/22 Piper Sandler
OncoCyte price target lowered to $1 from $1.50 at Piper Sandler
08/17/22 Piper Sandler
OncoCyte price target raised to $1.50 from $1.40 at Piper Sandler
08/11/22 Lake Street
OncoCyte price target lowered to $3 from $6 at Lake Street
05/24/22 Stephens
Stephens downgrades OncoCyte to Equal Weight on limited near-term upside
OCX OncoCyte
/

+

CDMO Avid Bioservices
$15.55 /

+0.565 (+3.77%)

  • 14
    Apr
CDMO Avid Bioservices
$15.55 /

+0.565 (+3.77%)

Over a quarter ago
Hot Stocks
Tomi to install custom engineered iHP System in Avid Bioservices facility » 08:41
10/10/22
10/10
08:41
10/10/22
08:41
TOMZ

Tomi Environmental Solutions

/

+

, CDMO

Avid Bioservices

$18.01 /

-0.61 (-3.28%)

TOMI Environmental…

TOMI Environmental Solutions (TOMZ) announced that it has recently received a purchase order for an iHP Custom Engineered System from Avid Bioservices (CDMO) for implementation in Avid's new purpose-built viral vector development and manufacturing facility in Costa Mesa, California. During site development, a SteraMist iHP Custom Engineered System will be implemented within four GMP manufacturing suites. This will require eleven applicators with a single control panel and a 55-gallon BIT solution container. Earlier this month, the TOMI team began working with Avid's team on planning the installation, which is projected to be finalized in the first half of 2023.

ShowHide Related Items >><<
TOMZ Tomi Environmental Solutions
/

+

CDMO Avid Bioservices
$18.01 /

-0.61 (-3.28%)

TOMZ Tomi Environmental Solutions
/

+

12/21/21 H.C. Wainwright
TOMI Environmental Solutions initiated with a Buy at H.C. Wainwright
CDMO Avid Bioservices
$18.01 /

-0.61 (-3.28%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$18.01 /

-0.61 (-3.28%)

CDMO Avid Bioservices
$18.01 /

-0.61 (-3.28%)

Hot Stocks
Avid Bioservices appoints Alston as VP, operations » 08:09
09/22/22
09/22
08:09
09/22/22
08:09
CDMO

Avid Bioservices

$18.31 /

+0.31 (+1.72%)

Avid Bioservices…

Avid Bioservices announced the appointment of Michael Alston, Jr. as vice president, VP, operations. Alston was promoted from Avid's director of project engineering, a role in which he led all of the company's ongoing facility expansions. In his new position, he will continue to oversee these projects including the Myford South expansion, as well as the construction of Avid's new dedicated cell and gene therapy facility.

ShowHide Related Items >><<
CDMO Avid Bioservices
$18.31 /

+0.31 (+1.72%)

CDMO Avid Bioservices
$18.31 /

+0.31 (+1.72%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$18.31 /

+0.31 (+1.72%)

CDMO Avid Bioservices
$18.31 /

+0.31 (+1.72%)

Earnings
Avid Bioservices reports Q1 EPS 2c vs. 10c last year » 16:09
09/06/22
09/06
16:09
09/06/22
16:09
CDMO

Avid Bioservices

$15.94 /

-0.14 (-0.87%)

Reports Q1 revenue $$36.7…

Reports Q1 revenue $$36.7 M, consensus $33.44M.

ShowHide Related Items >><<
CDMO Avid Bioservices
$15.94 /

-0.14 (-0.87%)

CDMO Avid Bioservices
$15.94 /

-0.14 (-0.87%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
CDMO Avid Bioservices
$15.94 /

-0.14 (-0.87%)

CDMO Avid Bioservices
$15.94 /

-0.14 (-0.87%)

Hot Stocks
Avid names Prem Patel as VP, process development, mammalian cell business » 08:31
09/01/22
09/01
08:31
09/01/22
08:31
CDMO

Avid Bioservices

$17.23 /

+0.27 (+1.59%)

, GSK

GSK

$32.48 /

-0.505 (-1.53%)

Avid Bioservices…

Avid Bioservices announced the appointment of Pramthesh Patel, Ph.D., as vice president, process development for its mammalian cell business. Prior to joining Avid, Dr. Patel spent more than 23 years at GSK, most recently serving as senior director. In this role he managed the team responsible for the company's mammalian cell culture and microbial fermentation process development for biopharmaceuticals.

ShowHide Related Items >><<
GSK GSK
$32.48 /

-0.505 (-1.53%)

CDMO Avid Bioservices
$17.23 /

+0.27 (+1.59%)

CDMO Avid Bioservices
$17.23 /

+0.27 (+1.59%)

06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
12/08/21 Craig-Hallum
Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
GSK GSK
$32.48 /

-0.505 (-1.53%)

08/26/22 Citi
Citi opens 'positive catalyst watches' on GSK, Sanofi after Zantac ruling
08/16/22 Oppenheimer
Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
08/15/22 RBC Capital
Haleon initiated with a Sector Perform at RBC Capital
08/15/22 Stifel
Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
GSK GSK
$32.48 /

-0.505 (-1.53%)

CDMO Avid Bioservices
$17.23 /

+0.27 (+1.59%)

GSK GSK
$32.48 /

-0.505 (-1.53%)

GSK GSK
$32.48 /

-0.505 (-1.53%)

CDMO Avid Bioservices
$17.23 /

+0.27 (+1.59%)

GSK GSK
$32.48 /

-0.505 (-1.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.